Bloomberg Audio Studios, Podcasts, Radio News.
The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.
Time now to look at some stocks on the move today here in Europe, and we're joined by Bloomberg reporter Chloe Malay. Good morning, Good morning.
Let's start with Nova Nordisk.
Gains there and that's due to an update from Berenberg. Yeah, absolutely so, some good news for Nova Nordisk after quite a few setbacks recently. As you said, it was raised to a BI rating at Behrenberg, which said that it now actually prefers Nova Nordisk over Eli Liddy, which obviously it's it's its biggest and most direct rival in that obesity weight loss space. Berenberg analyst said that Nova now has fresh ammunition to fight back against Eli Liddy thanks
to a few things. So there's been a few approval so we'll go. VI got us approval to treat a serious form of liver disease recently, there's approval for heart failure that's also expected towards the end of the year. And then another really big catalyst is going to be
the launch of oral, we'll go over next year. Elai Lidy's beast t pill looks also to be a potential major win for for Eli Lidly, but it doesn't prompts as much weight loss as as the shot, but it could be easier to produce, easier to use, maybe cheaper. So that could have been potentially another setback for nervan Ordist, but investors don't seem two phase by that, and the upgrade was seen as as a as a welcome boost and and Nevanadist chairs were up this morning on the
back of that. Despite this, this those good news from Elai Lily as well.
Let's talk utilities. Good news for Centrica from Morgan Stanley.
Yeah, Morgan Stanley upgraded Centrica to an overweight or by rating this morning. It said that it was now a top pick in the UK utility sector. It said the shares one we're not valuing fully valuing Centrica's existing business. But then there was also, in addition to that, potential upside from some of the deals that Centrica did recently. So that includes of course the nuclear stations side as well.
See so Centrica agreed to take a fifteen percent stake in that in that nuclear power plant, and then another deal was with Energy Capital Partners to jointly purchase the UK's a grain liquefied natural gas terminal from natural from sorry National Grade for one point five billion pounds. So those two deals are going to be creating a lot of upside for Centrica, according to Morgan Stanley. So it's all very positive in there in that utility sector, okay.
On Indo Text also skewing up. Why so Intertext, the owner of Zara, of course, upgraded to buy at ubs this morning. Analysts at Ubs said that they feel confident in Intertext's long term growth following a very strong start to the autumn winter season. They also said that there has been the quite a lot of shared decline over the last three quarters, which means that it was also
now quite an attractive entry point for Intertext. The good start to the season that they mentioned is is based on last week's update from ind Text, who said that the sales at the start of the third quarter were up nine percent and that was that drove the chares higher, and then this upgrade drove the chares even higher this morning.
There's still some concerns over tariffs over software consumer demand of course, and also some currency fluctuations that will probably weigh a little bit on intertext going forward, But so far, so far, so good, and a good start for that Spanish retailing sector as well.
The Stock Movers report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Apple, our Play and Android Auto with the Bloomberg Business app. Mm hmm.